US2004192635A1PendingUtilityA1
Acyl deoxyribonucleoside derivatives and uses thereof
Assignee: WELLSTAT THERAPEUTICS CORPPriority: Oct 28, 1987Filed: Apr 15, 2004Published: Sep 30, 2004
Est. expiryOct 28, 2007(expired)· nominal 20-yr term from priority
C07H 19/06C07H 19/10A61K 45/06
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to compositions comprising acyl derivatives of 2′-deoxyribonucleosides. The invention also relates to methods of treating or preventing radiation, mutagen and sunlight-induced cellular damage, methods for improving wound healing and tissue repair, and methods for ameliorating the effects of aging comprising administering the compositions of the present invention to an animal.
Claims
exact text as granted — not AI-modified1 - 55 (cancelled).
56 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxyadenosine, having the formula
wherein R 1 , R 2 , and R 3 are the same or different and each is hydrogen or an acyl group derived from
(a) an unbranched fatty acid with 3 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,
(c) nicotinic acid, or
(d) a dicarboxylic acid having 3 to 22 carbon atoms, provided that not all of R 1 , R 2 , and R 3 are H, and where R 3 is not H, then R 1 and/or R 2 may also be acetyl, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
57 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxyguanosine having the formula
wherein R 1 , R 2 , and R 3 are the same or different and each is hydrogen or an acyl group derived from
(a) an unbranched fatty acid with 3 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, phenylalanine, carnitine, and ornithine,
(c) nicotinic acid, or
(d) a dicarboxylic acid having 3 to 22 carbon atoms, provided that not all of R 1 , R 2 , and R 3 are H, and where R 3 is not H, then R 1 and/or R 2 may also be acetyl, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
58 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxycytidine, having the formula
wherein R 1 , R 2 , and R 3 are the same or different and each is hydrogen or an acyl group derived from
(a) an unbranched fatty acid with 3 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,
(c) nicotinic acid, or
(d) a dicarboxylic acid having 3 to 22 carbon atoms, provided that not all of R 1 , R 2, and R 3 are H, and where R 3 is not H, then R 1 and/or R 2 may also be acetyl, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
59 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxythymidine, having the formula
wherein R 1 is an acyl group derived from
(a) an unbranched fatty acid with 3 to 15 or 17 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,
(c) nicotinic acid, or
(d) a dicarboxylic acid having 3 to 22 carbon atoms, and R 2 and R 3 are H, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
60 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxythymidine, having the formula
wherein R 1 is H, R 2 is an acyl group derived from
(a) an unbranched fatty acid with 3 to 13 or 15 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,
(c) nicotinic acid, or
(d) a dicarboxylic acid with 3 to 22 carbon atoms, and R 3 is H or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
61 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxythymidine, having the formula
wherein R 1 and R 2 are the same or different and each is an acyl group derived from
(a) an unbranched fatty acid with 5 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,
(c) nicotinic acid, or
(d) a dicarboxylic acid with 3 to 22 carbon atoms, and R 3 is H or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
62 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an acyl derivative of 2′-deoxythymidine, having the formula
wherein R 1 and R 2 are the same or different and each is an acyl group derived from
(a) an unbranched fatty acid with 2 to 22 carbon atoms,
(b) an amino acid selected from the group consisting of glycine, the L forms of alanine, valine, leucine, isoleucine, tyrosine, proline, hydroxyproline, serine, threonine, cysteine, aspartic acid, glutamic acid, arginine, lysine, histidine, carnitine, and ornithine,
(c) nicotinic acid or
(d) a dicarboxylic acid with 3 to 22 carbon atoms, and R 3 is an acyl group derived from an optionally substituted benzoyl or heterocyclic carboxylic acid that is substantially nontoxic, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
63 . A method for treating or preventing radiation-induced cellular damage or sunlight-induced cellular damage comprising administering to an animal an effective amount of a composition comprising an effective amount of each of at least two compounds selected from at least two of the groups of compounds having formulae
wherein R 1 , R 2 , and R 3 are the same or different and each is H or an acyl group derived from a carboxylic acid, provided that at least one of said substituents R 1 , R 2 , and R 3 on each of said groups of compounds is not hydrogen, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.Join the waitlist — get patent alerts
Track US2004192635A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.